NOC — Northrop Grumman Corporation

Sentiment is guarded rather than bullish. NOC beat Q2 2026 consensus ($10.876B revenue, $7.68 EPS vs. ~$6.82 expected), yet shares fell ~2.2% after the print because operating margin contracted and FY2026 adjusted EPS guidance was trimmed to $28.60-$29.10. Wall Street still carries a Buy consensus with a $627.33 average target, but the stock's persistent underperformance versus the S&P 500 and defense-industrial peers shows the market is focused on fixed-price contract margins, not just backlog.

Revenue growth is stable-to-modestly accelerating: Q2 2026 was +5.1% YoY, Q1 2026 +4.4%, Q4 2025 +9.6%, Q3 2025 +4.3%. Margins are the weak spot: Q2 2026 operating margin was 10.1% versus an unusually strong 13.8% in Q2 2025, and TTM operating margin is about 10.2%. Q4 2023's operating loss and Q1 2025's 6.1% margin show the contract-charge lumpiness in this business. FCF is healthy but seasonal: TTM FCF through Q2 2026 is roughly $3.65B, with negative Q1s each year from working capital. Overall, this is a flat-to-slightly-compressing profit story, not a structural revenue decline.

As of 2026-08-27, the stock is fairly valued, modestly below its own history: TTM P/E is 17.3x, forward P/E is about 18.8x using FY2026 consensus EPS of $28.94, versus the 5-year average P/E of 19.34x. P/S is 1.81x versus the 5-year average 1.90x, and PEG is 1.08. The caveat: the forward P/E is higher than the trailing multiple because consensus expects EPS to fall from $31.64 TTM to $28.94, so this is not as cheap as the headline discount to 5-year P/E suggests.

At $545.13, the market is pricing roughly 18.8x forward earnings and appears to be assuming margins stay under pressure and EPS flatlines at the guided level rather than inflecting higher. If management stabilizes margins and B-21/Sentinel charges stop escalating, the stock should grind toward the $575-$600 area; if guidance gets cut again, the apparent valuation support at 17-18x earnings will not hold because estimates will fall with the price. The market is not pricing in a major earnings expansion, but it is also not giving NOC much benefit of the doubt.

As of 2026-08-27, the technical backdrop is neutral-to-soft: RSI was 44.8, price was 3.3% below the 20-day SMA, 0.6% above the 50-day SMA, and 9.7% below the 200-day SMA. That is a stock in a medium-term downtrend/consolidation, not oversold and not re-accelerating. The 52-week range is $479.02-$774.00; a reclaim of the 20-day/50-day area with volume would be a better entry trigger, while the $480 area is the more obvious support zone.

• Elevated global tensions in the Middle East, Eastern Europe, and Indo-Pacific continue to drive demand for missile defense, space, and autonomous systems.
• U.S. defense budget priorities are shifting toward space architectures and AI-enabled defense networks, which favors NOC's franchise but also creates program-selection risk.
• Persistent cost inflation in skilled labor and specialized materials is pressuring legacy fixed-price development contracts.
• Supply-chain frictions, especially in high-end electronics and solid rocket motors, create delivery-timing and margin risk.
• Interest-rate stabilization is supportive of defense multiples, but any renewed inflation/budget scare could re-rate the sector lower.

• Q3 2026 earnings in late October: updates on operating-margin stabilization, B-21 production ramp, and Sentinel progress.
• Golden Dome space-based missile defense architecture awards, where management says NOC is positioned for a significant share.
• Finalization of the sole-source RQ-4 Global Hawk sustainment contract into the 2030s.
• International growth acceleration (IBCS adoption, in-country solid rocket motor production in Australia) toward the $10B-by-2031 target.
• Next quarterly dividend of $2.47/share with ex-date 2026-08-31 and payment 2026-09-16.

• Additional fixed-price development contract charges, particularly on B-21 and Sentinel, could compress margins further.
• FY2026 EPS guidance of $28.60-$29.10 is below trailing EPS; a cut would make the valuation look more expensive.
• Congressional budget delays, continuing resolutions, or a defense-spending realignment away from NOC's key programs.
• Cost inflation and supply-chain bottlenecks persist in labor, electronics, and propulsion components.
• If the stock fails to reclaim moving averages, the $480 support zone could be tested before the story improves.

Northrop Grumman is a high-quality, strategically important defense franchise with durable revenue growth, strong free cash flow, and real optionality in space-based defense. But the near-term fundamental story is mixed: margins are compressing, FY2026 EPS is guided below trailing EPS, and the stock is not yet showing technical confirmation. At roughly 18.8x forward earnings with no clear margin inflection, the risk/reward is balanced — I would wait for a lower entry or evidence of margin stabilization before getting constructive.

I calculated fair value as 19.34x (NOC's 5-year average trailing P/E) applied to FY2026 consensus EPS of $28.94, yielding $559.70; using forward EPS avoids the flattering Q4 2025 TTM figure, and I added no premium to the historical multiple because margins are still compressing and FY guidance is below trailing EPS.